| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 26353-79-7 | 丙烯腈接枝的聚氧化丙烯與丙三醇(或季戊四醇)的加合物 | Polyoxypropylene adduct of glycerol or pentaerythritol grafted with acrylonitrile | 無(wú) | 詳情 | 供應(yīng)商 | |
| 137061-48-4 | 腺苷酸環(huán)化酶激活肽-38(抗原) | H-HIS-SER-ASP-gly-ile-PHE-thr-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-AL; H-HIS-SER-ASP-gly-ile-PHE-thr-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-gly-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; HIS-SER-ASP-gly-ile-PHE-thr-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-gly-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 無(wú) | C203H331N63O53S1 | 詳情 | 供應(yīng)商 |
| 81493-98-3 | 酪氨酸激酶 | H-ARG-ARG-LEU-ile-GLU-ASP-ASN-GLU-TYR-thr-ALA-ARG-gly-OH; ARG-ARG-LEU-ile-GLU-ASP-ASN-GLU-TYR-thr-ALA-ARG-gly; H-ARG-ARG-LEU-ile-GLU-ASP-ASN-GLU-TYR-thr-ALA-ARG-gly-OH; TYROSINE KINASE SUBSTRATE; RRLIEDNEYTARG; PP60(V-SRC) AUTOPHOSPHORYLATION SITE; PP60V-SRC FRAGMENT; arg-arg-leu-ile-glu-asp-asn-glu-tyr-*thr-ala-arg-; TYROSINE KINASE SUBSTRATE SYNTHETIC >96% |  | C66H109N23O23 | 詳情 | 供應(yīng)商 |
| 60786-59-6 | (thr4,gly7)-OXYTOCIN | CYS-TYR-ile-thr-ASN-CYS-gly-LEU-gly-NH2; thr(4)-gly(7)-oxytoci; [thr4, gly7] OT; [thr4, gly7]-OXYTOCIN; CYS-TYR-ile-thr-ASN-CYS-gly-LEU-gly-NH2; H-CYS-TYR-ile-thr-ASN-CYS-gly-LEU-gly-NH2; H-CYS-TYR-ile-thr-ASN-CYS-gly-LEU-gly-NH2, (DISULFIDE BOND); 3,3-DiallylthiacarbocyanineBromide |  | C39H63N11O12S2 | 詳情 | 供應(yīng)商 |
| 59392-49-3 | GASTRIC INHIBITORY POLYPEPTIDE (PORCINE) | GASTRIC INHIBITORY POLYPEPTIDE (PORCINE); H-TYR-ALA-GLU-gly-thr-PHE-ile-SER-ASP-TYR-SER-ile-ALA-MET-ASP-LYS-ile-ARG-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-gly-LYS-LYS-SER-ASP-TRP-LYS-HIS-ASN-ile-thr-GLN-OH; GASTRIC INHIBITORY PEPTIDE, PORCINE; GASTRIC INHIBITORY POLYPEPTIDE (PORCINE); GASTRIC INHIBITORY PEPTIDE, PORCINE (1-42); GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (PORCINE); GIP (PORCINE); GIP; YAEGTFISDYSIAMDKIRQQDFVNWLLAQKGKKSDWKHNITQ | 無(wú) | 詳情 | 供應(yīng)商 | |
| 100040-31-1 | GASTRIC INHIBITORY POLYPEPTIDE (HUMAN) | GIP (HUMAN); H-TYR-ALA-GLU-gly-thr-PHE-ile-SER-ASP-TYR-SER-ile-ALA-MET-ASP-LYS-ile-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-gly-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ile-thr-GLN-OH; GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (HUMAN); GASTRIC INHIBITORY PEPTIDE HUMAN; GASTRIC INHIBITORY POLYPEPTIDE (HUMAN); GIP (HUMAN); GIP; YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ; TYR-ALA-GLU-gly-thr-PHE-ile-SER-ASP-TYR-SER-ile-ALA-MET-ASP-LYS-ile-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-gly-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ile-thr-GLN | 無(wú) | C226H338N60O66S1 | 詳情 | 供應(yīng)商 |
| 99534-03-9 | thr-thr-TYR-ALA-ASP-PHE-ile-ALA-SER-gly-ARG-thr-gly-ARG-ARG-ASN-ALA-ile-HIS-ASP; thr-thr-TYR-ALA-ASP- | H-thr-thr-TYR-ALA-ASP-PHE-ile-ALA-SER-gly-ARG-thr-gly-ARG-ARG-ASN-ALA-ile-HIS-ASP-OH; H-TTYADFIASGRTGRRNAIHD; H-thr-thr-TYR-ALA-ASP-PHE-ile-ALA-SER-gly-ARG-thr-gly-ARG-ARG-ASN-ALA-ile-HIS-ASP-OH; CAMP DEPENDENT PK INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR-ALPHA (5-24) (HUMAN, MOUSE, RABBIT, RAT); ip20; TTYADFIASGRTGRRNAIHD; thr-thr-TYR-ALA-ASP-PHE-ile-ALA-SER-gly-ARG-thr-gly-ARG-ARG-ASN-ALA-ile-HIS-ASP |  | C94H148N32O31 | 詳情 | 供應(yīng)商 |
| 185032-24-0 | TYR-LYS-gly-(CYCLO(GLU26-LYS29),PRO34)-NEUROPEPTIDE Y (25-36) | H-TYR-LYS-gly-ARG-CYCLO(-GLU-TYR-ile-LYS)-LEU-ile-thr-ARG-PRO-ARG-TYR-NH2; H-TYR-LYS-gly-ARG-CYCLO(-GAMMA-GLU-TYR-ile-EPSILON-LYS)-LEU-ile-thr-ARG-PRO-ARG-TYR-NH2; H-TYR-LYS-gly-ARG-CYCLO(-GLU-TYR-ile-LYS)-LEU-ile-thr-ARG-PRO-ARG-TYR-NH2; TYR-LYS-gly-ARG-(GLU26,LYS29,PRO34)-NEURO-PEPTIDE Y (26-36); TYR-LYS-gly-(CYCLO(GLU26,LYS29),PRO34)-NEUROPEPTIDE Y (25-36); TYR-LYS-gly-(CYCLO(GLU26,LYS29),PRO34)-NPY (25-36) |  | 詳情 | 供應(yīng)商 | |
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-gly-LYS-SER-ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ile-ALA-GLU-ile-HIS-thr-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-gly-LYS-SER-ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ile-ALA-GLU-ile-HIS-thr-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-gly-LYS-SER-ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ile-ALA-GLU-ile-HIS-thr-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-gly-LYS-SER-ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ile-ALA-GLU-ile-HIS-thr-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-gly-LYS-SER-ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ile-ALA-GLU-ile-HIS-thr-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-gly-LYS-SER-ile-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ile-ALA-GLU-ile-HIS-thr-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 無(wú) | C180H287N57O48 | 詳情 | 供應(yīng)商 |
| 17998-69-5 | H-Tyr-Pro-ile-Lys-Pro-Glu-Ala-Pro-gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-thr-Arg-Pro-Arg-Tyr-NH2 | 無(wú) | 詳情 | 供應(yīng)商 |